Biocryst Pharmaceuticals (BO1.STU) Q2 2026 Earnings

6MayConfirmed
Q2 2026
-2.54
-1.68
-0.82
0.04

Details

Expected EPS
0.037671217
Actual EPS
-2.53598
Surprise EPS
-2.57
Surprise Percent
+6,831.88%

Description

Biocryst Pharmaceuticals (BO1.STU) has reported earnings of -2.53598 per share for Q2 2026.

0 Comments

Share your thoughts